Lawyer Profile
Howard M. Levine
Montréal, Québec
Overview
Howard advises clients on a broad range of M&A, corporate and securities transactions, both nationally and internationally. His experience covers all aspects of securities and business law, including public offerings, private placements, counsel to special committees of boards of directors, take-over bids, reverse take-over bids, plans of arrangement, proxy battles, venture capital investments, private equity transactions and private acquisitions. He also represents clients in their dealings with the Canadian securities commissions and stock exchanges and advises on continuous disclosure and corporate governance compliance.
Howard's clientele ranges from start-up companies obtaining their first round of financing to larger, more established companies listed on the TSX Venture Exchange (TSXV), the Toronto Stock Exchange (TSX) or the New York Stock Exchange (NYSE), and includes investment dealers and private equity and pension funds. His clients operate in a wide range of industries, including mining, manufacturing, software, information technology, financial services, transaction processing, energy, telecommunications, biotechnology, health products, consumer products and entertainment.
Matters on which Howard has acted recently as lead or co-lead counsel include representing:
A company operating in the process engineering business in connection with its sale to a US-based conglomerate
A TSX-listed company operating in the mobility sector in connection with the acquisition of one of its dealers
A TSX-listed company operating in the mining sector in connection with its acquisition of mining concessions in Brazil
A TSX-listed company operating in the mining sector in connection with its merger with a TSX Venture-Exchange-listed mining company by way of plan of arrangement and concurrent private placement financing
A TSX Venture Exchange-listed company operating in the biopharmaceutical sector in connection with its merger of equals transaction with a TSX and Nasdaq-dual listed biopharmaceutical company by way of a plan of arrangement
Practice Areas
Bar Information
Called to the bar: 1991 (QC)